Home › Funds › Bleichroeder LP › CLRB

Bleichroeder LP position in CLRB

Cellectar Biosciences Inc · Health Care

Bleichroeder LP reported holding 288,679 shares of CLRB (Cellectar Biosciences Inc) in its Q2 2026 13F filing — a position valued at US$803K, representing 0.14% of its reported portfolio and ranking #48 among its reported holdings. Bleichroeder LP has disclosed CLRB holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)288.68K sh
Reported value held$802.53K
Portfolio Weight0.14%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bleichroeder LP's CLRB position evolved

Bleichroeder LP first disclosed a stake in CLRB in Q3 2025 at 100,000 shares (US$560K). The position peaked in Q2 2026 at 288,679 shares, worth US$803K. Across 4 filings, Bleichroeder LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 288,679 shares valued at US$803K — an increase of 188,679 shares quarter over quarter.. Notable position changes include a 189% increase in Q2 2026 (shares fell 34% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 100.00K $560.00K New
Q4 2025 100.00K $295.00K Hold
Q1 2026 100.00K $254.00K Hold
Q2 2026 288.68K $802.53K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CLRB and 13F data

CLRB (Cellectar Biosciences Inc) is a Health Care company. 23 other funds we track also report a position in CLRB — the largest reported positions include Caligan Partners LP (US$1.3M), Empery Asset Management, LP (US$527K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CLRB

All CLRB fund holders →

FAQ

How long has Bleichroeder LP held CLRB?

Bleichroeder LP has disclosed CLRB holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Bleichroeder LP's current position in CLRB?

As of Q2 2026, Bleichroeder LP holds 288.68K shares of CLRB (Cellectar Biosciences Inc), valued at $802.53K, representing 0.14% of its reported portfolio and ranking #48.

Has Bleichroeder LP been buying or selling CLRB?

In the latest 13F filing (Q2 2026), Bleichroeder LP increased its position in CLRB. The position peaked in Q2 2026 at 288.68K shares.

Which other funds hold CLRB?

Other major institutional holders of CLRB include Caligan Partners LP, Empery Asset Management, LP, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.